share_log

B of A Securities Maintains Buy on Xenon Pharmaceuticals, Raises Price Target to $56

B of A Securities Maintains Buy on Xenon Pharmaceuticals, Raises Price Target to $56

Bof A证券维持对Xenon Pharmicals的买入,将目标股价上调至56美元
Benzinga ·  01/02 10:48

B of A Securities analyst Jason Gerberry maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy and raises the price target from $52 to $56.

B of A Securities分析师杰森·格伯里维持Xenon Pharmicals(纳斯达克股票代码:XENE)的买入并将目标股价从52美元上调至56美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发